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Background: Paragangliomas of the head and neck are rare tumors. Moreover, malignant paragangliomas of the
cervical spine are extremely rare. Currently, the combination of curative surgical resection and secondary adjuvant
radiotherapy is the gold standard for treating symptomatic malignant paragangliomas. However, traditional
treatments for malignant paraganglioma remain unsuccessful. The purpose of this study is to report an exceedingly
rare case involving cervical metastasis of a malignant paraganglioma.
Case presentation: In this case report, we present a case involving a 72-year-old male with a history of paraganglioma
of the neck. He had been experiencing bilateral shoulder pain, neck pain and weakness in the upper extremities for
more than six months. Magnetic resonance imaging of the cervical spine revealed a metastasis at C4 with severe
vertebral body destruction. To avoid serious complications associated with surgical resection, CyberKnife® radiosurgery
(Accuray, Inc., Sunnyvale, CA, USA) was performed on the parapharyngeal and cervical lesions. A secondary surgery,
which involved a posterior laminectomy at C3-6 and posterior fusion at C1-T1, was performed two weeks after the
radiosurgery. A histological examination of the surgical specimen demonstrated a malignant paraganglioma. The
patient regained strength in all extremities in the postoperative field, and his pain was dramatically reduced. A
magnetic resonance imaging study performed three months after the surgery showed a reduced tumor size and
spinal cord decompression.
Conclusion: This case study is the first report of a patient with symptomatic cervical metastasis of a malignant
paraganglioma treated with a combination of radiosurgery and posterior spinal surgery. Although the optimal
treatment for these conditions remains unclear, concomitant treatment with radiosurgery and reconstructive
surgery appeared to be both safe and effective in this challenging case.
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Paragangliomas are highly vascular tumors that arise from
paraganglia. Of these, head and neck paragangliomas are
rare, accounting for about 0.03% of all tumors [1]. Malig-
nant paragangliomas are exceedingly rare. Currently, the
combination of curative surgical resection and secondary
adjuvant radiation is the gold standard for treating symptom-
atic malignant paragangliomas [2,3]. However, the postopera-* Correspondence: inoorth@tmd.ac.jp
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reproduction in any medium, provided the ortive complications are considerable. To our knowledge,
the combined surgical and radiosurgical treatment for ma-
lignant paragangliomas described in this study have not
been reported previously. This report describes a patient
with severe neck pain and myelopathy.Case presentation
We report a rare case of symptomatic cervical metastasis
of a malignant paraganglioma in a 72-year-old male. Five
years prior to presentation, the patient visited another
hospital presenting with neck swelling and hoarseness.
He was diagnosed with paraganglioma of the neck, buttd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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prior to presentation, the patient’s chief complaints were
bilateral shoulder pain, severe neck pain and weakness
of the upper extremities. Because of the continual pain, he
was referred to us for a second opinion. A physical exam-
ination revealed clumsiness in both hands and muscle
weakness in the upper extremities. Cervical roentgeno-
grams revealed a lytic lesion of the C3,4,5 vertebral body.
Cervical computerized tomography (CT) revealed destruc-
tion of the C3,4,5 vertebral body and C4 lamina. Magnetic
resonance imaging (MRI) (Figure 1) demonstrated severe
canal stenosis at the C4 level, with spinal cord deform-
ation. An MRI of the neck upon admission showed a large
soft-tissue tumor in the parapharyngeal space, which was
adherent to the left carotid artery. A positron emission
tomography (PET) scan (Figure 2) revealed lytic lesions of
the C4 and L1 vertebrae and a parapharyngeal space
lesion near the carotid body.b
a
Figure 1 Sagittal (a) and axial (b) T2-weighted magnetic
resonance image displaying marked C4 destruction and severe
canal stenosis.
Figure 2 Positron emission tomography-computed tomography
showing pathological fluorodeoxyglucose uptake in the neck
(top) and in the C4 (top), L1 (bottom) vertebral bodies.As the tumor was extremely large and close to the artery
and nervous tissue, the head and neck surgeons avoided
this treatment route. The conventional anterior approach
to the vertebral body was also rendered impossible be-
cause of the obstruction of the primary neck tumor.
Therefore, CyberKnife® radiosurgery (Accuray, Inc.) was
employed as the primary treatment for the cervical and
parapharyngeal lesions. Even after the radiosurgery, the
pain and weakness in the upper limbs persisted. We con-
cluded that it would take some time for the effect of radio-
surgery to appear, as his severe neck pain was caused by
the destruction of vertebrae. Consequently, a C3-6 lamin-
ectomy and C1-T1 fusion using pedicle screw fixation was
also performed. The highly vascularized tumor on the C4
lamina was removed and sent to the pathology depart-
ment. A histological examination (Figure 3) revealed a
malignant paraganglioma. Immediately after the second
operation, the patient displayed significant improvement
in pain and upper-extremity weakness without any com-
plications. As for the metastasis in the lumbar lesion, the
Figure 3 Microscopic findings revealing polygonal cells with
eosinophilic cytoplasms within a prominent vascular
component (the typical zellballen structures, H&E 200×).
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diation was administered. Three months after the second
operation, an MRI (Figure 4) confirmed that the tumor
had shrunk, and the spinal cord compression had disap-
peared. The last follow-up (six months after the second
operation) demonstrated complete recovery of the upper-
extremity strength.Figure 4 Postoperative sagittal (a) and axial (b) T2-weighted
magnetic resonance image showing a reduced tumor size and
spinal cord decompression.Discussion
Paraganglioma is a rare and slow-growing tumor that
arises from extra-adrenal chromaffin cells and accounts
for 0.3% of all neoplasms [4]. Malignant paraganglioma
accounts for 3% of paragangliomas. Malignant paragan-
gliomas are defined by findings of local recurrence or
presence of metastatic spread of tumors. Vertebral me-
tastases of malignant paraganglioma are exceedingly un-
common. Amongst these, cervical vertebral metastases
are the rarest [3]. To the best of our knowledge, only ten
isolated reports exist [2,3,5-7]. The symptoms caused by
cervical spinal metastases are predominantly the conse-
quence of the tumor’s mass effect on local structures,
such as the spinal cord and vertebral body.
Paraganglioma can be diagnosed by measuring the cate-
cholamines and metanephrines in the plasma or urine. CT
or MRI can identify the location of the paraganglioma.
Additionally, 131I-metaiodobenzylguanidine (MIBG), a pre-
cursor of noradrenaline, scintigraphy has a sensitivity of
77%–90% and a specificity of 95%–100% in detecting
paragangliomas [8]. However, while reduced 131I-MIBG
sensitivity has been demonstrated in some cases, PET has
been found to be superior to 131I-MIBG scintigraphy
[9,10]. Our case showed a pathological 18 F-fluorodeoxy-
glucose (FDG) uptake in the neck and in the C4, L1 verte-
bral bodies on PET.Pathologically, a Ki-67 index <1% is considered a useful
parameter for predicting benign potential [11]. In our
case, the histological findings were compatible with ma-
lignant paraganglioma, showing a Ki-67 index > 1%, pol-
ygonal cells with eosinophilic cytoplasm in a prominent
vascular component (the typical Zellballen structures),
and lastly positive staining for chromogranin, synapto-
physin and CD56.
Currently, the combination of curative surgical resection
and secondary adjuvant radiotherapy is the gold standard
for treating symptomatic malignant paragangliomas [2,3].
Surgical resection is effective; however, these procedures
contain potential risks, such as massive bleeding, spinal
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I131-MIBG remains the only other non-surgical treatment
that has produced tumor responses >30% [10]. However,
this treatment has not been confirmed to be effective in
tumors that lack MIBG uptake. Most importantly, the
procedure is not curative.
Recently, radiosurgery has emerged as an effective tool
for managing paraganglioma [12]. Radiosurgery delivers
external radiation in a focused manner, allowing for
much higer doses to be given with fewer side effects to
the surrounding normal tissue [13]. Guss et al. have re-
ported that 97% of patients with paraganglioma achieve
tumor control through radiosurgery, the results are
comparable to that of surgery [14,15]. However, no stud-
ies have specifically investigated the use of CyberKnife®
radiosurgery for a malignant paraganglioma [16]. Thus,
its application has not been well established. In our case,
according to the MRIs before and after radiosurgery,
tumor mass was markedly reduced. If the radiosurgery
had such a great effect on tumor control, there should
be the question that posterior fusion surgery might not
have been needed. However, even after the radiosurgery,
his severe neck pain and muscle weakness continued.
We thought that these symptoms were caused by the in-
stability of the spine due to the destruction of the verte-
bral body and continuous spinal cord compression.
Therefore, we think this case also needed the posterior
decompression and fusion surgery.
Conclusions
In summary, we report a rare case of symptomatic
cervical metastasis of a malignant paraganglioma. Ra-
diosurgery followed by dorsal spinal surgery led to
rapid improvement of the paresis and pain. Postopera-
tive imaging findings and clinical outcome revealed
the safety and effectiveness of combined surgery and
radiosurgery. However, additional follow-ups are ne-
cessary to detect local recurrence and the spread of
other lesions.
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